Revenues: Total revenues for the first quarter of fiscal 2026 were $144.1 million, a 13% increase from $128.1 million in the ...

Tuesday closed up +2.05%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +1.78%, and the Nasdaq 100 Index ($IUXX) ...

Nordson Corp (NDSN) is expected to report $2.20 for 2Q. Nutanix Inc (NTNX) is expected to report $0.05 for 3Q. Ooma Inc (OOMA) is expected to report $-0.01 for 1Q. Photronics Inc (PLAB) is expected to ...

Kezar Life Sciences, Inc. , a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that Chris Kirk, Chief ...

Innocan Pharma Corporation (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies is pleased to announce its financial ...

U.S. stock futures traded flat to slightly up in Tuesday’s overnight session after the euphoria over the U.S.-European Union ...

In nCino’s public disclosures, nCino has provided non-GAAP measures, which are measurements of financial performance that have not been prepared in accordance with generally accepted accounting ...

Non-GAAP Financial MeasuresIn nCino’s public disclosures, nCino has provided non-GAAP measures, which are measurements of financial performance that have not been prepared in accordance with ...

Total Revenues of $144.1M, up 13% year-over-year• Subscription Revenues of $125.6M, up 14% year-over-year WILMINGTON, N.C., May 28, 2025 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the leading ...

Total Revenues of $144.1M, up 13% year-over-year “Strong execution drove financial results above guidance, underscoring our ability to deliver value for shareholders and customers,” said Sean Desmond, ...